Lucas Onder, Chrysa Papadopoulou, Almut Lütge, Hung-Wei Cheng, Mechthild Lütge, Christian Perez-Shibayama, Cristina Gil-Cruz, Angelina De Martin, Lisa Kurz, Nadine Cadosch, Natalia B. Pikor, Regulo Rodriguez, Diana Born, Wolfram Jochum, Pawel Leskow, Andre Dutly, Mark D. Robinson, Burkhard Ludewig
{"title":"Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer","authors":"Lucas Onder, Chrysa Papadopoulou, Almut Lütge, Hung-Wei Cheng, Mechthild Lütge, Christian Perez-Shibayama, Cristina Gil-Cruz, Angelina De Martin, Lisa Kurz, Nadine Cadosch, Natalia B. Pikor, Regulo Rodriguez, Diana Born, Wolfram Jochum, Pawel Leskow, Andre Dutly, Mark D. Robinson, Burkhard Ludewig","doi":"10.1016/j.cell.2024.10.042","DOIUrl":null,"url":null,"abstract":"Stringent control of T cell activity in the tumor microenvironment is essential for the generation of protective antitumor immunity. However, the identity, differentiation, and functions of the cells that create critical fibroblastic niches promoting tumor-infiltrating T cells remain elusive. Here, we show that CCL19-expressing fibroblastic reticular cells (FRCs) generate interconnected T cell environments (TEs) in human non-small cell lung cancer, including tertiary lymphoid structures and T cell tracks. Analysis of the FRC-T cell interactome in TEs indicated molecular networks regulating niche-specific differentiation of CCL19-expressing fibroblasts and T cell activation pathways. Single-cell transcriptomics and cell fate-mapping analyses in mice confirmed that FRCs in TEs originate from mural and adventitial progenitors. Ablation of intratumoral FRC precursors decreased antitumor T cell activity, resulting in reduced tumor control during coronavirus vector-based immunotherapy. In summary, specialized FRC niches in the tumor microenvironment govern the quality and extent of antitumor T cell immunity.","PeriodicalId":9656,"journal":{"name":"Cell","volume":"18 1","pages":""},"PeriodicalIF":45.5000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.cell.2024.10.042","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Stringent control of T cell activity in the tumor microenvironment is essential for the generation of protective antitumor immunity. However, the identity, differentiation, and functions of the cells that create critical fibroblastic niches promoting tumor-infiltrating T cells remain elusive. Here, we show that CCL19-expressing fibroblastic reticular cells (FRCs) generate interconnected T cell environments (TEs) in human non-small cell lung cancer, including tertiary lymphoid structures and T cell tracks. Analysis of the FRC-T cell interactome in TEs indicated molecular networks regulating niche-specific differentiation of CCL19-expressing fibroblasts and T cell activation pathways. Single-cell transcriptomics and cell fate-mapping analyses in mice confirmed that FRCs in TEs originate from mural and adventitial progenitors. Ablation of intratumoral FRC precursors decreased antitumor T cell activity, resulting in reduced tumor control during coronavirus vector-based immunotherapy. In summary, specialized FRC niches in the tumor microenvironment govern the quality and extent of antitumor T cell immunity.
严格控制肿瘤微环境中 T 细胞的活性对产生保护性抗肿瘤免疫至关重要。然而,创造促进肿瘤浸润 T 细胞的关键成纤维细胞龛的细胞的身份、分化和功能仍然难以捉摸。在这里,我们发现表达 CCL19 的成纤维网状细胞(FRC)在人类非小细胞肺癌中产生了相互连接的 T 细胞环境(TE),包括三级淋巴结构和 T 细胞轨道。对TEs中FRC-T细胞相互作用组的分析表明,分子网络调控着表达CCL19的成纤维细胞和T细胞活化途径的龛特异性分化。对小鼠进行的单细胞转录组学和细胞命运图谱分析证实,TE 中的成纤维细胞起源于壁细胞和临近细胞的祖细胞。瘤内 FRC 前体的消融降低了抗肿瘤 T 细胞的活性,从而导致冠状病毒载体免疫疗法的肿瘤控制率降低。总之,肿瘤微环境中特化的 FRC 龛决定着抗肿瘤 T 细胞免疫的质量和程度。
期刊介绍:
Cells is an international, peer-reviewed, open access journal that focuses on cell biology, molecular biology, and biophysics. It is affiliated with several societies, including the Spanish Society for Biochemistry and Molecular Biology (SEBBM), Nordic Autophagy Society (NAS), Spanish Society of Hematology and Hemotherapy (SEHH), and Society for Regenerative Medicine (Russian Federation) (RPO).
The journal publishes research findings of significant importance in various areas of experimental biology, such as cell biology, molecular biology, neuroscience, immunology, virology, microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. The primary criterion for considering papers is whether the results contribute to significant conceptual advances or raise thought-provoking questions and hypotheses related to interesting and important biological inquiries.
In addition to primary research articles presented in four formats, Cells also features review and opinion articles in its "leading edge" section, discussing recent research advancements and topics of interest to its wide readership.